Boehringer Ingelheim has achieved a significant milestone in the treatment of interstitial lung diseases with the approval of Jascayd (nerandomilast)…
Read More
AI-Powered "GPS" Model Marks Paradigm Shift in Drug Discovery, Identifies Candidates for Liver Cancer and Pulmonary Fibrosis
A groundbreaking machine-learning model, dubbed "GPS" (Gene Expression Profile Predictor on Chemical Structures), has been unveiled by a multi-institute collaboration…
Read More
